
Symprove has provided £1,500 of funding
On behalf of Symprove I am proud to give my backing to IBDrelief.Symprove is first and foremost an R&D company. Our position is underpinned by independent research from Kings College Hopsital, London that shows our effectiveness in the area of digestive health and particularly IBS and IBD. Our company ethos is firmly based on science and our objective is to provide as much education as possible to sufferers.These goals and ethos correspond strongly to those of IBDRelief, namely to change the landscape for IBD suffers by raising awareness of the condition.By bringing together the knowledge and experience of both sufferers and experts, I firmly believe IBDrelief will create a unique information resource and an invaluable platform for suffers.Barry SmithFounder and Chairman Symprove www.symprove.com